Aegis Capital Still Positive on Rosetta Genomics (ROSG) Following Q4 Results; Nudges Ests Higher
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Rosetta Genomics (ROSG) Files $75M Mixed Shelf
March 23, 2016 4:48 PM EDTRosetta Genomics (NASDAQ: ROSG) filed a registration with the U.S. SEC to sell, from time to time, up to $75 million worth of mixed securities.
... MoreRosetta Genomics (ROSG) Reports Q4 Loss Per Share of $0.14
March 23, 2016 4:16 PM EDTRosetta Genomics (NASDAQ: ROSG) reported Q4 EPS of ($0.14). Revenue for the quarter came in at $3.6 million, versus $698 thousand reported last year.
For earnings history and earnings-related data on Rosetta Genomics (ROSG) click here.
... MoreTrading Radar for 3/23: General Mills (GIS), Fuel Tech (FTEK), KB Home (KBH), StemCells (STEM) Report
March 22, 2016 2:54 PM EDTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
7:00am EDT
Earnings:
CTI Industries Corp (Nasdaq: CTIB) - no Street consensus... More
